vs
American Healthcare REIT, Inc.（AHR）与Qorvo, Inc.（QRVO）财务数据对比。点击上方公司名可切换其他公司
Qorvo, Inc.的季度营收约是American Healthcare REIT, Inc.的1.8倍（$993.0M vs $564.0M），Qorvo, Inc.净利率更高（16.5% vs 1.9%，领先14.6%），American Healthcare REIT, Inc.同比增速更快（13.5% vs 8.4%），过去两年American Healthcare REIT, Inc.的营收复合增速更高（11.7% vs 2.7%）
本公司是一家国际医疗房地产投资信托基金（REIT），总部位于美国阿拉巴马州伯明翰，主要在美国及欧洲地区收购、投资医疗机构与营利性医疗控股企业，物业收购多采用售后回租模式，租户通常签署长期三净租约。
Qorvo是一家美国跨国企业，专注于无线、有线及电源市场相关产品的研发与供应。该公司由TriQuint半导体与RF Micro Devices合并而来，合并计划于2014年公布，2015年1月1日正式完成，在纳斯达克挂牌上市，股票代码QRVO，原实行双总部制，2016年中起将北卡罗来纳州基地作为总部所在地。
AHR vs QRVO — 直观对比
营收规模更大
QRVO
是对方的1.8倍
$564.0M
营收增速更快
AHR
高出5.2%
8.4%
净利率更高
QRVO
高出14.6%
1.9%
两年增速更快
AHR
近两年复合增速
2.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $564.0M | $993.0M |
| 净利润 | $10.8M | $164.1M |
| 毛利率 | 14.8% | 46.7% |
| 营业利润率 | 19.8% | 19.4% |
| 净利率 | 1.9% | 16.5% |
| 营收同比 | 13.5% | 8.4% |
| 净利润同比 | 133.9% | 297.5% |
| 每股收益（稀释后） | $0.07 | $1.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AHRQRVO
| Q4 25 | $564.0M | $993.0M | ||
| Q3 25 | $532.1M | $1.1B | ||
| Q2 25 | $501.3M | $818.8M | ||
| Q1 25 | $497.2M | $869.5M | ||
| Q4 24 | $496.8M | $916.3M | ||
| Q3 24 | $476.8M | $1.0B | ||
| Q2 24 | $458.0M | $886.7M | ||
| Q1 24 | $452.1M | $941.0M |
净利润AHRQRVO
| Q4 25 | $10.8M | $164.1M | ||
| Q3 25 | $55.9M | $119.6M | ||
| Q2 25 | $9.9M | $25.6M | ||
| Q1 25 | $-6.8M | $31.4M | ||
| Q4 24 | $-31.8M | $41.3M | ||
| Q3 24 | $-4.1M | $-17.4M | ||
| Q2 24 | $2.0M | $414.0K | ||
| Q1 24 | $-3.9M | $2.7M |
毛利率AHRQRVO
| Q4 25 | 14.8% | 46.7% | ||
| Q3 25 | 14.6% | 47.0% | ||
| Q2 25 | 15.0% | 40.5% | ||
| Q1 25 | 13.0% | 42.2% | ||
| Q4 24 | 13.3% | 42.7% | ||
| Q3 24 | 12.5% | 42.6% | ||
| Q2 24 | 12.1% | 37.5% | ||
| Q1 24 | 10.7% | 40.6% |
营业利润率AHRQRVO
| Q4 25 | 19.8% | 19.4% | ||
| Q3 25 | 19.9% | 14.9% | ||
| Q2 25 | 20.6% | 3.7% | ||
| Q1 25 | 19.0% | 3.2% | ||
| Q4 24 | 20.0% | 5.8% | ||
| Q3 24 | 19.6% | 0.9% | ||
| Q2 24 | 19.4% | 0.5% | ||
| Q1 24 | 18.2% | 3.2% |
净利率AHRQRVO
| Q4 25 | 1.9% | 16.5% | ||
| Q3 25 | 10.5% | 11.3% | ||
| Q2 25 | 2.0% | 3.1% | ||
| Q1 25 | -1.4% | 3.6% | ||
| Q4 24 | -6.4% | 4.5% | ||
| Q3 24 | -0.9% | -1.7% | ||
| Q2 24 | 0.4% | 0.0% | ||
| Q1 24 | -0.9% | 0.3% |
每股收益（稀释后）AHRQRVO
| Q4 25 | $0.07 | $1.75 | ||
| Q3 25 | $0.33 | $1.28 | ||
| Q2 25 | $0.06 | $0.27 | ||
| Q1 25 | $-0.04 | $0.33 | ||
| Q4 24 | $-0.23 | $0.43 | ||
| Q3 24 | $-0.03 | $-0.18 | ||
| Q2 24 | $0.01 | $0.00 | ||
| Q1 24 | $-0.04 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $114.8M | $1.3B |
| 总债务越低越好 | — | $1.5B |
| 股东权益账面价值 | $3.3B | $3.7B |
| 总资产 | $5.4B | $6.2B |
| 负债/权益比越低杠杆越低 | — | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资AHRQRVO
| Q4 25 | $114.8M | $1.3B | ||
| Q3 25 | $147.4M | $1.1B | ||
| Q2 25 | $133.5M | $1.2B | ||
| Q1 25 | $86.1M | $1.0B | ||
| Q4 24 | $76.7M | $769.4M | ||
| Q3 24 | $67.8M | $1.1B | ||
| Q2 24 | $52.1M | $1.1B | ||
| Q1 24 | $77.0M | $1.0B |
总债务AHRQRVO
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
股东权益AHRQRVO
| Q4 25 | $3.3B | $3.7B | ||
| Q3 25 | $2.7B | $3.5B | ||
| Q2 25 | $2.4B | $3.4B | ||
| Q1 25 | $2.3B | $3.4B | ||
| Q4 24 | $2.3B | $3.4B | ||
| Q3 24 | $2.2B | $3.4B | ||
| Q2 24 | $1.9B | $3.5B | ||
| Q1 24 | $2.0B | $3.6B |
总资产AHRQRVO
| Q4 25 | $5.4B | $6.2B | ||
| Q3 25 | $4.8B | $6.1B | ||
| Q2 25 | $4.5B | $6.0B | ||
| Q1 25 | $4.5B | $5.9B | ||
| Q4 24 | $4.5B | $6.0B | ||
| Q3 24 | $4.7B | $6.5B | ||
| Q2 24 | $4.6B | $6.4B | ||
| Q1 24 | $4.7B | $6.6B |
负债/权益比AHRQRVO
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.44× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.2M | $265.4M |
| 自由现金流经营现金流 - 资本支出 | — | $236.9M |
| 自由现金流率自由现金流/营收 | — | 23.9% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | 5.12× | 1.62× |
| 过去12个月自由现金流最近4个季度 | — | $595.2M |
8季度趋势，按日历期对齐
经营现金流AHRQRVO
| Q4 25 | $55.2M | $265.4M | ||
| Q3 25 | $107.2M | $84.0M | ||
| Q2 25 | $71.5M | $182.9M | ||
| Q1 25 | $60.6M | $199.2M | ||
| Q4 24 | $59.5M | $214.1M | ||
| Q3 24 | $63.1M | $127.8M | ||
| Q2 24 | $59.4M | $81.1M | ||
| Q1 24 | $-6.0M | — |
自由现金流AHRQRVO
| Q4 25 | — | $236.9M | ||
| Q3 25 | — | $42.2M | ||
| Q2 25 | — | $145.4M | ||
| Q1 25 | — | $170.7M | ||
| Q4 24 | — | $176.2M | ||
| Q3 24 | — | $94.8M | ||
| Q2 24 | — | $42.9M | ||
| Q1 24 | — | — |
自由现金流率AHRQRVO
| Q4 25 | — | 23.9% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | — | 19.6% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | — | 9.1% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | — |
资本支出强度AHRQRVO
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | — |
现金转化率AHRQRVO
| Q4 25 | 5.12× | 1.62× | ||
| Q3 25 | 1.92× | 0.70× | ||
| Q2 25 | 7.21× | 7.15× | ||
| Q1 25 | — | 6.35× | ||
| Q4 24 | — | 5.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | 30.02× | 195.86× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
QRVO
| ACG | $690.8M | 70% |
| HPA | $190.9M | 19% |
| CSG | $111.3M | 11% |
